Account
A new study has found that the drug Axitnib may delay the development of kidney cancer for longer than other treatments, according to researchers from the Cleveland Clinic.Compared to another drug, Sorafenib, Axitnib was more effective in preventing disease progression of renal cell carcinoma, the most prevalent form of kidney cancer."There was a two-month advantage to Axitnib to Sorafenib in this setting," said lead researcher Dr. Brian Rini, an oncologist at the Cleveland Clinic's Taussig Cancer Institute.Rini said the information will allow oncologists to build a better treatment plan for certain kidney cancer patients."What makes people feel bad with cancer is tumor-burden causing fatigue and lack of appetite or sometimes pain," he said. "So, by delaying the time until worsening, you are in essence buying time without symptoms."The study was published in the journal Lancet ....
This week, America lost one of its greatest innovators to what was likely a recurrence of the pancreatic cancer he had battled for years. Steve Jobs , the co-founder...
A combination of hand sanitizer, olive oil and static electricity likely caused an accidental fire that burned a young patient at a Portland hospital, the state fire...
No scars. No long recovery. Find out how doctors are now able to treat kidney cancer by using just a needle to destroy tumors
In seven months on the job, Bill O'Brien has turned into much more than just the new leader of the Penn State Nittany Lions.Perhaps no head coach has ever inherited ...
Rates of two rare childhood cancers declined after the U.S. began requiring grain products to be fortified with the B vitamin folic acid, a new study finds.Reported ...
Penn State tailback Silas Redd still stands by his former coach Joe Paterno. Defensive tackle Jordan Hill does, too.Redd, Hill and the rest of the Nittany Lions are ...
A cancer drug that isn't passing muster in clinical trials may still be the answer for some patients, a new study says.Researchers at Memorial Sloan-Kettering Cancer...
Health regulators on Tuesday approved a Pfizer Inc pill for a rare type of leukemia, another step in the company's effort to expand its oncology business.The medicin...
The genetic cause of a syndrome that causes stunted growth in babies has eluded scientists since it was discovered 20 years ago. Now, a gene mutation thought to be l...
This fingertip-size device can't exactly cough, but it can get a lung disease. For the first time, researchers have reproduced some of the effects of a disease in a ...
The genetic cause of a syndrome that causes stunted growth in babies has eluded scientists since it was discovered 20 years ago. Now, a gene mutation thought to be l...
Health regulators granted a priority review for Bayer's colorectal cancer drug regorafenib, potentially speeding up the experimental treatment's route to market.The ...
Eating red meat may increase a person's risk of developing the most common type of kidney cancer, while eating vegetables may provide a protective effect, new resear...
The Food and Drug Administration has approved a new treatment for an advanced form of kidney cancer, the agency announced Tuesday.In trials, kidney cancer patients t...
Pfizer Inc. said its kidney cancer drug did not meet the main goal of showing a statistically significant improvement in survival in a late-stage trial without the c...
In a stunning example of when treatment might be worse than the disease, a large review of Medicare records finds that older people with small kidney tumors were muc...
People who eat lots of red meat may have a higher risk of some types of kidney cancer , suggests a large U.S. study.Researchers found that middle-aged adults who ate...
Study questions kidney cancer treatment
A Pfizer Inc. drug won speedy federal approval Thursday to combat a rare stomach cancer and advanced kidney cancer.Sunitinib , to be marketed as Sutent , is the firs...